EVERSANA’s Post

Read the article: https://ow.ly/zuXm50SkgRw Accelerated approvals, staying abreast of rapid changes in data and navigating regulatory intricacies further complicate the commercialization of #oncology therapies. Consequently, challenges like infrastructure, risk spending, and communicating value arise. Learn about considerations and innovative approaches to enhance your commercialization strategies.

Great insights here from Sean Rapson from EVERSANA CONSULTING and John Kenny, PhD with EVERSANA INTOUCH on the power that #GenAI can bring to the brand planning process.

DOWNLOAD THE ARTICLE: https://ow.ly/rtxC50SrNgC The European Parliament has adopted a revision of pharmaceutical legislation, aiming to enhance medicine supply security, improve accessibility and support EU pharmaceutical innovation. Download the article for insights from EVERSANA's experts, Monique Martin, SVP of Value and Evidence, and Mike Ryan, GM of Europe, about how to navigate the changing environment.

We’re #proud all year long but #pride2024 was a wonderful chance to reflect, empower and unite with our global team. Our LGBTQIA+ Professional Network Co-Chairs illuminate the celebrations: Michael Tatasciore: “To me, this year's Pride initiatives were impactful because we got to host and hear from an incredibly wide and diverse group of people that span multiple gender identities, orientations, backgrounds and ethnicities, showing how vast the queer experience is, and how many people make up our incredible queer community." Metta Chase: “The Pride initiatives showed me, once again, what a positive and supportive environment EVERSANA is. It’s encouraging to see engagement from such a variety of people, both from within the queer community and from so many allies.” Thank you to our proud employees for speaking up this month and throughout the year for equitable and diverse impact.  #pride #WeAreEVERSANA #culture Heather Rae Martin, STEM MBA Healthcare Strategist

Learn more about NAVLIN by EVERSANA: https://ow.ly/KBim50SpYAh Increasingly complex global commercial launches are driving demand for accurate, actionable and easy-to-understand insights at your fingertips – insights that tell you not just what is going right or wrong with your global commercial strategy, but why – and do so early enough to improve the real value of a therapy over its lifecycle. As newly appointed Senior Vice President of Product Development for EVERSANA, Gustav Ando is responding to this unmet industry need by leading the development of world-class pricing, market access, and commercial insights from NAVLIN by EVERSANA’s market-leading data and software, using technology, data, forecasting and AI tools to drive getting pharmaceutical assets to patients around the world faster.

How can EVERSANA helps clients navigate the patient journey? Explore our Market Access resource library to learn more: https://ow.ly/GuQf50Si4iE Patient engagement is pivotal to building trust, ensuring transparency and driving better health outcomes. EVERSANA’s comprehensive patient engagement solutions, which leverage cutting-edge technology and personalized strategies, ensure patients are actively involved in their care, driving demand and access for new products and fostering long-term patient loyalty. EVERSANA’s Key Strategies for Driving Patient Engagement: 1. Leverage strategic marketing expertise. 2. Facilitate effective communication about a product’s value proposition. 3. Cultivate brand awareness. 4. Distinguish offerings within the competitive landscape. 5. Drive greater patient access through direct-to-patient care models. #PatientEngagement #HealthcareSolutions #EVERSANA

Read the article: https://ow.ly/bEqE50ShpNQ Our Value & Evidence team at EVERSANA, in collaboration with other HEOR industry experts, has critically reviewed and synthesized worldwide Indirect Treatment Comparison (#ITC) guidelines. Considering the challenges of head-to-head #clinicaltrials, ITCs provide valuable insights into clinical effectiveness. These insights help regulators and reimbursement agencies make informed decisions, improving patient access to novel treatments. Recent methodological advancements have led to global guidelines outlining jurisdiction-specific methodology and best practices. This comprehensive #literaturereview highlights key ITC techniques for objective analyses and ascertains the circumstantial suitability of ITCs as a source of comparative evidence for healthcare interventions. Krista Tantakoun, Christopher Olsen, Fatemeh Mirzayeh Fashami, @Imtiaz Samjoo and Chris Cameron

Register for the webinar: https://ow.ly/8N7L50S0LU1 Join EVERSANA’s Marty Culjat for an insightful webinar on #PDURS and the #FDA's new framework for incorporating software into drug labels! This #webinar, hosted by pharmaphorum will take a deep dive into the FDA's proposed framework that allows #pharmaceutical manufacturers to add software to drug labels, provided they can demonstrate clinical benefits. This innovative move is set to revolutionize the way we look at drug labeling and patient care. #PrescriptionDrug UseRelatedSoftware #Webinar

Discover More: https://lnkd.in/eCwwiJzS Maria Bucceri Kirsch, President, Patient Services at EVERSANA highlights the importance of leveraging technology and collaboration to enhance patient support programs for those with rare diseases in PM360 Magazine. #RareDiseases #PatientSupport #HealthcareInnovation #EVERSANA